Meghmani Organics aims to achieve double-digit growth in the crop protection sector, with a strategic emphasis on expanding their business and reducing debt.

Meghmani Organics' Q4 profit dipped significantly by 59.6%, reaching ₹8 crore, and the revenue decreased by 14.3% compared to last year. The decline in earnings before interest, taxes, depreciation, and amortization (EBITDA) was even more pronounced at 70%, standing at ₹19.7 crore, resulting in a drop in margin from 11.8% to 4.1%.

Meghmani Organics reported a significant year-over-year drop in Q4 net profit, with earnings totaling just ₹80 million compared to ₹198 million last year. This indicates a steep decrease in profitability for the quarter.

QE Securities has offloaded approximately 1.37 million shares of Meghmani Organics at an average price of around ₹57.8 each, as per the National Stock Exchange's bulk trades data.

Meghmani Organics has received approval from the Ministry of Agriculture to produce nano fertilizers, including Nano DAP, Nano NPK, and Nano Zinc, with production set to begin before the Kharif season.

Thermax partners with Ankur Scientific to construct India's first Green Methanol plant, contributing to the nation's green energy objectives. Meghmani Organics has received approval for Nano Fertiliser production, while Afcons and Dynacons secure significant infrastructure contracts.

Thermax, Meghmani Organics, Afcons Infrastructure, and Dynacons are set to be the key companies under watch today in the stock market. Investors might want to keep a close eye on their performance throughout the trading day.

The National Company Law Tribunal (NCLT) has approved the merger plan for Meghmani Organics, which includes joining forces with Kilburn Chemicals and Meghmani Crop Nutrition. Meetings will take place on June 6, 2026, through video conferencing, with details to be posted on Meghmani's website.

Meghmani Organics Ltd's rating outlook has been downgraded by CRISIL to 'Negative' from 'Stable', reflecting potential risks in the company's financial position. The total bank loans rated for the company amount to ₹1,094 crore, with short-term ratings maintained at Crisil A1 and long-term ratings adjusted accordingly.

Meghmani Organics will hold a board meeting on May 9, 2026, to review the financials for their fiscal year ending March 31, 2026. The agenda includes approving standalone and consolidated results, as well as the statutory audit report for FY 2025-26.

Kilburn Chemicals received a positive loan outlook upgrade from India Ratings. This change is based on improved financial conditions and reflects an optimistic future for the company's INR 2,742 million loan facilities.

Meghmani Organics Ltd is consolidating its operations by merging two of its subsidiaries into the main company, aiming for a simpler organizational structure. This move does not involve issuing new shares or altering the existing shareholding, with assets being transferred to Meghmani Organics Ltd.

Meghmani Organics Ltd has approved the consolidation of subsidiaries Kilburn Chemicals Ltd and Meghmani Crop Nutrition Ltd. This move is intended to optimize operations, combine resources, reduce costs, and strengthen financial interplay.

Meghmani Organics Ltd has experienced a third consecutive drop, reaching an all-time low of Rs 37. This decline exceeds recent losses in the Dyes & Pigments sector and the Sensex index.

Meghmani Organics has scheduled a board meeting on April 4, 2026, for the review and approval of a proposed amalgamation scheme. The aim is to finalize this significant consolidation move.